Get the Stockscreener App
22.45
0.02%
0.055
Surgery Partners Inc stock is traded at $22.45, with a volume of 91,959.
It is up +0.02% in the last 24 hours and up +3.04% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$22.50
Open:
$22.57
24h Volume:
91,959
Relative Volume:
0.05
Market Cap:
$2.89B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-83.13
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-4.80%
1M Performance:
+3.04%
6M Performance:
-13.01%
1Y Performance:
-24.93%
1-Day Range:
$22.48
$22.59
1-Week Range:
$22.25
$23.82
52-Week Range:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
22.51 | 3.02B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
388.52 | 91.37B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
169.05 | 15.18B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.09 | 14.58B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
119.18 | 12.00B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
177.66 | 11.36B | 16.08B | 1.20B | 1.06B | 17.82 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Director’s Major Stock Sale at Surgery Partners! - TipRanks
Surgery Partners’ SWOT analysis: healthcare stock navigates pricing pressures - Investing.com
Surgery Partners announces $1.38 billion refinancing of credit agreement By Investing.com - Investing.com Canada
Surgery Partners announces $1.38 billion refinancing of credit agreement - Investing.com
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal - MSN
Surgery Partners Announces Credit Agreement Amendment - TipRanks
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know | FinancialContent - FinancialContent
Surgery Partners- units enter second amendment to credit agreementSEC filing - MarketScreener
Surgery Partners director Maryland sells $455k in shares - Investing.com
Surgery Partners director Maryland sells $455k in shares By Investing.com - Investing.com South Africa
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
SGRY Q2 Deep Dive: Orthopedics and De Novo Expansion Drive Steady Growth - Yahoo Finance
Can Surgery Partners Inc. sustain its profitabilityCEO Change & Real-Time Sentiment Analysis - thegnnews.com
Surgery Partners Inc. Could See a Relief Rally From SupportReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
Surgery Partners, Inc. (NASDAQ:SGRY) Q2 2025 Earnings Call Transcript - MSN
Can Surgery Partners Inc. hit a new high this monthNeural Model for Stock Price Movement - Newser
Published on: 2025-08-08 23:19:54 - Newser
Long term hold vs stop loss in Surgery Partners Inc.High Confidence Strategy with Trend Alignment - Newser
Candlestick signals on Surgery Partners Inc. stock todaySmart Trade Forecast Based on Neural Logic - Newser
Insider Sales and Shareholder Confidence in Surgery Partners (SGRY): A Closer Look at CFO David Doherty's $1.11 Million Transaction - AInvest
Surgery Partners Insider Sold Shares Worth $1,110,814, According to a Recent SEC Filing - MarketScreener
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY) - Defense World
Surgery Partners Reports Revenue Growth Amid Net Loss - TipRanks
Capitalizing on Undervalued Sectors: Why Brown & Brown and Surgery Partners Are Strategic Buys in a Shifting Market - AInvest
Surgery Partners Appoints New Chairman After Resignation - The Globe and Mail
Surgery Partners, Inc. shares rise 1.76% intraday after UNC Health Rex Hospital and Brasseler Surgical collaboration. - AInvest
Surgery Partners outlines $200M acquisition target and signals leverage reduction focus amid robust organic growth - MSN
Surgery Partners stock rating reiterated by Benchmark on solid positioning - Investing.com South Africa
Surgery Partners: Q2 Earnings Snapshot - Huron Daily Tribune
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - MSN
Surgery Partners 2025 Q2 Earnings Strong Performance as Net Income Surges 58.1% - AInvest
Surgery Partners Inc (SGRY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Surgery Partners (SGRY) Q2 Revenue Up 8% - The Motley Fool
Surgery Partners Inc. Earnings Call: Growth Amid Challenges - TipRanks
Surgery Partners, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations By Investing.com - Investing.com Canada
Earnings call transcript: Surgery Partners beats Q2 2025 earnings expectations - Investing.com
Surgery Partners' Q2 2025: Unraveling Contradictions in M&A Strategy, Financial Goals, and Legislation Impact - AInvest
Surgery Partners Q2 Financial Results: Surpassing ExpectationsNews and Statistics - IndexBox
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance - MSN
Surgery Partners (NASDAQ:SGRY) Surprises With Q2 Sales - Yahoo Finance
Surgery Partners Q2 Adjusted Earnings Fall, Revenue Rises; Reaffirms 2025 Revenue Guidance - MarketScreener
Surgery Partners Inc Reports Q2 2025 Revenue of $826.2M, Exceedi - GuruFocus
Surgery Partners reports Q2 adjusted EPS 17c, consensus 14c - TipRanks
Surgery Partners Inc earnings beat by $0.01, revenue topped estimates - Investing.com Australia
Surgery Partners beats Q2 expectations, reaffirms 2025 guidance By Investing.com - Investing.com Canada
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):